Announced on its homepage: “INVESTORS The Noema team successfully raised a 54 million Swiss Franc (USD59 million/EUR50 million) Series A financing round co-led by So…”.
Observed on the company’s website; business claims are not independently verified.
Our earliest capture with readable facts. This is our first observation, not when the company introduced these things. These website claims are not independently verified.
All facts above belong to this capture. Unlisted fields mean we have no readable observation, not that they were absent.
How it describes itself
Similar headlines are grouped together. The quote shown is from the last capture in each group, not necessarily the exact wording throughout that period.
January 2026 – November 2026 · 2 captures · latest observed messagingDRIVING BETTER OUTCOMES
DRIVING BETTER OUTCOMES Advancing therapeutics designed to deliver superior clinical benefit across both orphan and broader neurology indications Who we are...
14 January 2026 · DRIVING BETTER OUTCOMESarchived page
6 November 2026 · DRIVING BETTER OUTCOMEScurrent websiteHistorical capture not publicly available
December 2020 – July 2025 · 9 capturesBEYOND SYMPTOM CONTROL
BEYOND SYMPTOM CONTROL Developing therapies to help both orphan and larger patient populations with conditions of the brain and nervous system live their li...